Skip to main content
. 2005 Feb;54(2):282–288. doi: 10.1136/gut.2003.036426

Figure 6.

Figure 6

 Effect of 6-hydroxydopamine on intracisternal corticotropin releasing factor (CRF) induced alterations in hepatic surface perfusion (A) and portal venous pressure (B) in urethane anaesthetised rats. 6-Hydroxydopamine was intraperitoneally injected seven days before (100 mg/kg) and four days before (80 mg/kg) intracisternal injection of CRF (2 nmol). For other details, see legend to fig 1. Each point represents the mean (SEM). *p<0.05, **p<0.01 compared with the vehicle treated group.